Instillido (Lidocaine Hydrochloride)

Lidocaine hydrochloride blocks voltage‑gated sodium channels on nerve membranes, preventing the influx of sodium ions that are required for the generation and propagation of action potentials. This inhibition stops nerve impulse transmission, producing a reversible loss of sensation in the treated area.

The appropriate dose of Instillido is determined by the prescribing clinician based on the specific procedure, patient characteristics, and the required depth of anesthesia. Healthcare professionals calculate the volume needed to achieve effective local anesthesia while minimizing systemic exposure.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and it should be prescribed by a qualified healthcare professional after careful assessment.

To order Instillido, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Instillido’s lidocaine hydrochloride is an amide‑type local anesthetic offering rapid onset and moderate duration of action. Compared with ester‑type anesthetics, lidocaine generally provides a longer anesthetic window and a lower incidence of allergic reactions, making it a common choice for urethral procedures.

Instillido should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and sterility until use.

Instillido is administered directly into the urethra using a sterile applicator or catheter. The clinician instills the recommended volume of the solution onto the urethral mucosa, allowing it to take effect within minutes before proceeding with the intended procedure.

Serious risks include systemic toxicity leading to central nervous system symptoms such as seizures, cardiac arrhythmias, and severe allergic reactions like anaphylaxis. Prompt recognition of these signs and immediate medical intervention are essential to mitigate adverse outcomes.

Instillido should be avoided in patients with a known hypersensitivity to lidocaine, other amide‑type local anesthetics, or any component of the formulation. Caution is also advised for individuals with severe hepatic impairment, significant cardiac conduction disorders, or those taking interacting medications listed under major interactions.